Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome

Authors

  • J. Guinea,

    1.  Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense
    2. ) CIBER de Enfermedades Respiratorias (CIBERES CD06/06/0058), Palma de Mallorca
    Search for more papers by this author
  • M. Torres-Narbona,

    1.  Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense
    Search for more papers by this author
  • P. Gijón,

    1.  Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense
    Search for more papers by this author
  • P. Muñoz,

    1.  Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense
    2. ) CIBER de Enfermedades Respiratorias (CIBERES CD06/06/0058), Palma de Mallorca
    Search for more papers by this author
  • F. Pozo,

    1. ) CIBER de Enfermedades Respiratorias (CIBERES CD06/06/0058), Palma de Mallorca
    2. ) Pneumology Department and Clinical Epidemiology Unit, Hospital Universitario Doce de Octubre
    Search for more papers by this author
  • T. Peláez,

    1.  Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense
    2. ) CIBER de Enfermedades Respiratorias (CIBERES CD06/06/0058), Palma de Mallorca
    Search for more papers by this author
  • J. de Miguel,

    1. ) Pneumology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain
    Search for more papers by this author
  • E. Bouza

    1.  Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense
    2. ) CIBER de Enfermedades Respiratorias (CIBERES CD06/06/0058), Palma de Mallorca
    Search for more papers by this author

Corresponding author and reprint requests: J. Guinea, Servicio de Microbiología Clínica y Enfermedades Infecciosas-VIH, Hospital General Universitario Gregorio Marañón, C/Dr Esquerdo, 46, 28007 Madrid, Spain
E-mail: jguineaortega@yahoo.es

Abstract

Clin Microbiol Infect 2010; 16: 870–877

Abstract

We describe a large series of patients with chronic obstructive pulmonary disease (COPD) and probable invasive pulmonary aspergillosis (IPA), and the risk factors and incidence of the disease in patients with isolation of Aspergillus from lower respiratory tract samples. From 2000 to 2007, we retrospectively studied all patients admitted with COPD and isolation of Aspergillus (239; 16.3/1000 admissions). Multivariate logistic regression and survival curves were used. Fifty-three patients had probable IPA (3.6 cases of IPA per 1000 COPD admissions). IPA affects at least 22.1% of patients with COPD and isolation of Aspergillus in culture. In 33 of the 53 patients with probable IPA, serum galactomannan was determined; in 14 (42.4%) of these, the result was positive. Five variables were independent predictors of IPA with statistical significance: admission to the intensive-care unit, chronic heart failure, antibiotic treatment received in the 3 months prior to admission, the accumulated dosage of corticosteroids equivalent to >700 mg prednisone received in the 3 months prior to admission, and the similar accumulated dosage of corticosteroids received from admission to the first clinical isolation of Aspergillus. Multivariate analysis gave an area under the curve of 0.925 (95% CI 0.888–0.962; p <0.001). The overall mean survival of the cohort was 64.1% (28.3% for IPA patients and 75.2% for non-IPA patients). The median number of days of survival was 48 (95% CI 33.07–62.92). However, we found statistically significant differences between patients with IPA (29 days; 95% CI 20.59–37.40) and patients without IPA (86 days; 95% CI 61.13–110.86) (log rank, p <0.001).

Ancillary